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Polychlorinated aromatic hydrocarbons,
including polychlorinated biphenyls (PCBs),
polychlorinated dibenzo-p-dioxins (PCDDs),
and polychlorinated dibenzofurans (PCDFs),
are industrial compounds that are contami-
nants in chemical manufacturing processes or
by-products in the combustion of organic
materials. They are widely found in the envi-
ronment and in chemical-waste dump sites.
Because of their lipophilic nature, halo-
genated aromatic compounds bioaccumulate
in the food chain. Residues have been
detected in foods and in human adipose tis-
sue, milk, and serum fat (1).
The toxicity of dioxin-like compounds is
mediated through binding to the aryl hydro-
carbon receptor (AhR) (2). Upon receptor–
ligand binding, the complex is translocated to
the nucleus and binds to the dioxin-respon-
sive elements of the DNA, which subse-
quently induces the transcription of genes, for
instance, encoding for metabolic enzymes.
More recently, interference of polyhalo-
genated aromatic hydrocarbons (PHAHs) or
their metabolites with other hormone recep-
tors has also been observed (3).
Polychlorinated aromatic xenobiotics
elicit a broad spectrum of biologic and toxic
responses. Toxic responses include dermal
toxicity, immunotoxicity, carcinogenicity,
and adverse effects on reproductive, neu-
robehavioral, and endocrine functions (4,5).
Experiments in which laboratory animals
and nonhuman primates have been exposed
to PCDD/PCDFs and/or PCBs indicate
that the immune system is perhaps the most
sensitive target for PHAH-induced toxicity.
Indeed, 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) causes cellular and humoral
immune suppression, increased susceptibility
to various infectious diseases, thymus atro-
phy, and depressed antibody and lympho-
proliferative responses (6–11). Moreover, in
wildlife, PCBs/dioxins affect the survival of
birds, seals, and beluga whales by diminish-
ing host resistance and increasing incidence
and severity of infections (12,13).
Accidental or occupational exposure as
well as background exposure of the general
population to PCBs and dioxins may affect
the human immune system (7,8,14–18).
There is suggestive evidence that dioxin-like
compounds inﬂuence the immune response
by changing the CD4/CD8 ratio, the ratio
of other lymphocyte populations, or the
antibody production by B cells (4,7,8,15,
16,18,19). As in animals, an increased sus-
ceptibility to infectious diseases has been
noted in adults and children (16,20,21).
In this study, we investigated whether
lifetime exposure of Flemish adolescents to
PCBs and dioxin-like compounds is associ-
ated with alterations in the immune system
and immunologically mediated health effects.
Methods
Study area. Hoboken and Wilrijk, two adja-
cent suburbs of the city of Antwerp,
Belgium, are located 11–13 km southeast of
the chemical and petrochemical industry in
Antwerp’s seaport. They are also the seat of
several small and medium-sized enterprises, a
large primary nonferrous smelter (mainly
Hoboken), two waste incinerators (Wilrijk),
and a crematory (Wilrijk). The two suburbs
are traversed by highways with a trafﬁc den-
sity > 80,000 vehicles per day. The two waste
incinerators near and in Wilrijk have been in
operation since 1971 and 1980, respectively.
In 1997, when they were shut down, they
had annual turnovers of 23,000 and 110,000
tons (22). The dioxin levels in topsoil sam-
ples obtained in 1997 at a depth of 3–5 cm
at 15 sites in a radius of 0.5–3.0 km around
the incinerators ranged from 3.9 to 27.2 ng
toxic equivalents (TEQ)/kg dry weight
(mean, 9.8 ng) (22). In contrast, the town of
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In this study, we investigated 17- to 18-year-old boys and girls to determine whether changes in
humoral or cellular immunity or respiratory complaints were related to blood serum levels of
polychlorinated biphenyls (PCBs) and dioxin-like compounds after lifetime exposure in Flanders
(Belgium). We obtained blood samples from and administered questionnaires to 200 adolescents
recruited from a rural area and two urban suburbs. Physicians recorded medical history and respi-
ratory diseases. We measured immunologic biomarkers such as differential blood cell counts, lym-
phocyte phenotypes, and serum immunoglobulins. As biomarkers of exposure, we determined the
serum concentrations of PCBs (PCB 138, PCB 153, and PCB 180) and dioxin-like compounds
[chemical-activated luciferase expression (CALUX) bioassay]. The percentages of eosinophils and
natural killer cells in blood were negatively correlated with CALUX toxic equivalents (TEQs) in
serum (p = 0.009 and p = 0.05, respectively). Increased serum CALUX TEQs resulted in an
increase in serum IgA levels (p = 0.05). Furthermore, levels of speciﬁc IgEs (measured by radioal-
lergosorbent tests) of cat dander, house dust mite, and grass pollen were also significantly and
negatively associated with the CALUX TEQ, with odds ratios (ORs) equal to 0.63 [95% conﬁ-
dence interval (CI), 0.42–0.96], 0.68 (0.5–0.93), and 0.70 (0.52–0.95), respectively. In addition,
reported allergies of the upper airways and past use of antiallergic drugs were negatively associ-
ated with CALUX TEQs, with ORs equal to 0.66 (0.47–0.93) and 0.58 (0.39–0.85), respectively.
We found a negative association between IgGs and marker PCBs in serum (p = 0.009). This
study shows that immunologic measurements and respiratory complaints in adolescents were
associated with environmental exposure to polyhalogenated aromatic hydrocarbons (PHAHs).
The negative correlation between PHAHs and allergic responses in adolescents suggested that
exposure may entail alterations in the immune status. Key words: biomonitoring, biomarkers,
CALUX, immunotoxicity, polychlorinated biphenyls. Environ Health Perspect 110:595–600
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away from the nearest nonferrous and chemi-
cal plants and lie away from major road axes.
Study population. The study population
was recruited in 1999, just after the Belgian
PCB and dioxin incident (23). The target
population of the study consisted of 355
adolescents born in 1980–1983 who were in
the last 2 years of secondary school and who
resided in the suburbs Hoboken and Peer.
After informed written consent had been
obtained from the parents, 207 adolescents
(58% of those invited) agreed to participate.
Seven adolescents were excluded from the
study because they had recently moved (n =
3) or because they were not immediately
available for study because of illness (n = 2)
or holidays (n = 2). 
Nonresponders had characteristics similar
to those of the participants (24). The adoles-
cents (100 from Peer, 42 from Wilrijk, and
58 from Hoboken) were examined at their
schools between 20 May and 2 December
1999. Examinations started in Peer (May–
June), went on in Wilrijk (July–August),
resumed in Peer (September–October), and
ﬁnally took place in Hoboken (November–
December). 
School physicians recorded medical his-
tory (based on the International Classiﬁcation
of Diseases) (25), in particular, allergic com-
plaints during the past year. Questionnaires
were administered to assess lifestyle, dietary
habits, smoking and drinking habits, intake
of medications, and social class of the par-
ents. Demographic and sociodemographic
characteristics of the participants in the three
areas are described elsewhere (24).
Blood sample collection. We collected
blood samples in the morning and separated
serum immediately. We divided serum into
three parts for individual analysis of
immunoglobulins (2 mL), indicator PCB
congeners (3 mL), and chemical-activated
luciferase expression (CALUX) TEQ (2.5
mL). We immediately froze samples of
serum and blood for determination of indi-
cator PCBs; we stored immunoglobulin and
CALUX TEQ samples at 4°C; and we
transported samples for phenotyping and
hematology (at room temperature) to the
laboratories within 6 hr for further process-
ing. We performed total and differential
blood cell counts on whole blood samples.
Immune phenotyping. We performed
two-color flow cytometric immunopheno-
typing using the lysed whole blood method
(Becton Dickinson, San Jose, CA, USA) to
determine the following lymphocyte subsets:
CD19+ B lymphocytes, CD3+ T lympho-
cytes, CD3+CD4+ T-helper lymphocytes,
CD3+CD8+ T-suppressor lymphocytes,
CD45+ leukocytes, and CD16+CD56+ nat-
ural killer (NK) cells. We used the following
Simultest Kits from Becton-Dickinson:
CD45–fluorescein isothiocyanate (FITC),
CD3-FITC/CD4-phycoerythrin (PE),
CD3-FITC/CD8-PE, CD3-FITC/CD19-
PE, CD3-FITC/CD16+CD56-PE, and γ1-
FITC/γ1-PE control. We stained CD-Chex
PLUS from Becton-Dickinson with the
same antibodies to serve as an intralab 
quality control.
We incubated 100 µL aliquots of whole
blood with 20 µL antibody for 30 min at
room temperature in the dark. After we
lysed incubation erythrocytes using Facs
lysing solution (Becton-Dickinson), we
washed and subsequently fixed them with
1% paraformaldehyde. We performed anti-
body staining and flow cytometry within 6
hr after blood sampling. We performed lym-
phocyte gating on forward/sideward scatter
dot blots using CD45-FITC–labeled blood
cells. Quality control criteria included that
the gated population must contain 95%
CD45+ cells.
We performed all analyses using a
FacsStar Plus cytometer (Becton-Dickinson)
equipped with a 488 nm argon air-cooled
laser. We used CellQuest software (Becton-
Dickinson) for data acquisition and data
analyses. Lymphocyte subsets are expressed
as percentage of the gated lymphocytes.
Determination of serum immunoglobu-
lins. We used an ELISA method to measure
IgA, IgG, IgM, and IgE levels in serum, and
we tested hypersensitivity by specific IgE
measurements [radioallergosorbent tests
(RASTs)]. The antigens tested included
house dust mite, cat dander, grass pollen, and
birch. We considered the IgE RAST mixtures
positive if their value was > 0.70 kU/L.
Indicator PCBs. As described elsewhere
(26,27), we measured the lower (congeners
28, 52, and 101) and higher (congeners 138,
153, and 180) chlorinated PCBs in serum as
biomarkers of exposure to PCBs. Brieﬂy, the
samples were vortexed with formic acid for
homogenization, followed by two steps of
solvent-extraction of PCBs (n-heptane) and
purification of extracts by a silica gel col-
umn. We performed PCB analyses on a
high-resolution gas chromatograph with
electron capture detection equipped with
two capillary columns of different polarity.
We identiﬁed the PCBs by means of reten-
tion times and carried out quantification
using Mirex as internal standard. The detec-
tion limit for each congener was 0.015
ng/mL. For internal quality control, we
included a blind and a control sample in
each series of measurements.
CALUX bioassay. Measurement of the
serum dioxin concentration would have
required an additional 50 mL of blood. We
therefore estimated exposure to dioxin-like
compounds via the CALUX bioassay
(BioDetection Systems BV, Amsterdam,
The Netherlands), an in vitro assay that
requires only 2.5 mL of serum and is mecha-
nistically based. In this assay, we assessed
dioxin-like compounds via in vitro activation
of the AhR of cultured H4IIE cells (28–31).
The method involved n-hexane extrac-
tion of 2.5 mL of blood serum and removal
of matrix components by passage through a
33% H2SO4 silica column. We partly evapo-
rated the extract, quantitatively transferred it
to a conical vial for further evaporation, and
reconstituted it in dimethyl sulfoxide (Acros
Organics, Geel, Belgium) for CALUX mea-
surement using the rat hepatoma H4IIE cell
line transfected with an AhR-controlled
luciferase reporter gene construct (CALUX
assay). We grew cells in 96-well plates in
100 µL of minimal essential medium (Gibco,
NV Invitrogen SA, Merelbeke, Belgium) with
10% fetal calf serum (Gibco) at 37°C with 5%
CO2. When the cell layer reached 70–80%
conﬂuency, we treated the cells with samples
and TCDD standards in quadruplicate and
incubated the cells for 24 hr. After removing
the medium, we washed the cells with
100 µL phosphate-buffered saline without
calcium and magnesium (Gibco) and added
30 µL of cell lysis reagent (Promega, Benelux
BV, Leiden, The Netherlands). We then
shook the well plates for at least 45 min and
stored them at –80°C for at least 1 hr. For
determination of luciferase activity, we
thawed the cells on ice and added 100 µL of
luciferin assay mix (Promega) at room tem-
perature. We measured the light production
using a Victor 2 Luminometer (EG&G
Wallac, Oosterhout, The Netherlands). We
calculated the CALUX-based TEQs by com-
paring the luciferase activity induced by the
sample with a dose–response curve generated
from TCDD concentration standards ana-
lyzed simultaneously. 
Statistical analysis. Database management
and statistical analysis were performed with
SAS, version 6.12 (SAS Institute, Cary, NC,
USA) and Statistica, version 99 (Statsoft,
Tulsa, OK, USA). We log-transformed data
that were not normally distributed and
described continuous data by the arithmetic
mean ± 95% conﬁdence interval (CI) or the
geometric mean with 95% CI. We used
dichotomous classifications to code for the
presence of allergic diseases and positive aller-
gic tests. We used the Student’s t-test and
Fisher’s exact test to compare means and pro-
portions, respectively, between girls and boys. 
We identified confounding variables by
stepwise multiple regression or logistic
regression. The p-value for variables to enter
and to stay in the model was set at 0.05. We
checked the following covariables: sex,
smoking habits, alcohol consumption, his-
tory of infectious or allergic diseases, familial
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smoking habits during pregnancy, having
been breast-fed, body mass index, social class
of the parents, use of oral contraceptives,
and mean atmospheric ozone concentrations
and mean daily temperatures during the
week before blood sampling (both obtained
from the Royal Meteorological Institute,
Brussels, Belgium).
We calculated dose–effect relations in
individual subjects between the biomarkers
of immunologic effects and those reﬂecting
exposure to PHAHs, using multiple linear
regression for continuous outcomes or logis-
tic regression for categorical variables.
Results
Characteristics of the participants. The 200
adolescents (mean age ± SD, 17.4 ± 0.8
years) included 120 girls (60%). Mean age
(17.3 vs. 17.4 years), mean body mass index
(21.2 kg/m2 vs. 21.1 kg/m2), proportions of
current smokers (25%), social class of par-
ents (23% workers, 64% middle class, 12%
educated professionals), and breast-fed sub-
jects (56%) were similar in girls and boys.
Compared with girls, more boys consumed
alcohol (29% vs. 65%). Among the girls,
41% were on oral contraceptives.
The red blood cell count and the total
and differential white blood cell counts are
shown in Table 1. The hematologic measure-
ments were within the normal ranges. 
The lower chlorinated PCB congeners
28, 53, and 101 in the adolescents were all
below their respective limits of detection
(0.16, 0.21, and 0.18 nmol/L). PCB con-
gener 153 represented the major fraction
(46%) of the combined marker PCBs, and
congeners 138 and 180 each accounted for
27% of the total. For all further analyses, we
combined congeners 138, 153, and 180. 
The mean serum concentrations of the
marker PCBs were 0.99 and 1.67 nmol/L in
girls and boys, respectively, whereas CALUX
TEQ was similar in both sexes, 0.15 and
0.16 pg/mL serum, respectively (Table 1).
The percentages of adolescents with pos-
itive RAST tests or positive personal or
familial histories of allergic or bronchial dis-
orders appear in Table 2.
Dose–effect relations. We computed
dose–effect (Table 3) and dose–response
(Table 4) relationships between the biomark-
ers of exposure and various immunologic
measurements or the odds of showing a posi-
tive test or history of allergic or bronchial dis-
orders. We tested a large number of potential
confounding variables. The following vari-
ables did not reach statistical significance,
and were not included in any of the regres-
sion models: alcohol consumption, smoking
of mother during pregnancy, having been
breast-fed, body mass index, social class of
parents, use of oral contraceptives, mean
atmospheric ozone concentrations, and
mean daily temperatures during the week
before blood sampling. The variables for
which our analyses were adjusted are listed
in Tables 3 and 4.
The eosinophil count was negatively and
independently correlated with the serum
concentrations of dioxin-like compounds (p
= 0.009; Table 3). Monocytes tended to
decrease with increasing serum TEQ values
(p = 0.055; Table 3). We observed a negative
association, although at borderline signifi-
cance, between the number of NK cells
(CD16+CD56+) and the serum concentra-
tion of dioxin-like compounds (p = 0.05;
Table 3). We found no significant associa-
tions between the other lymphocyte pheno-
types and either serum TEQ values or the
combined serum concentrations of PCB
congeners 138, 153, and 180 (Table 3). We
obtained similar results when we expressed
lymphocyte subpopulations as absolute
numbers (cells per milliliter).
The dioxin-like activity in the serum was
negatively correlated with serum IgE levels
(p = 0.02) but positively correlated with IgA
concentrations (p = 0.05; Table 3). We
found a negative correlation between IgG
levels and the concentration of the combined
marker PCBs (p=0.009; Table 3).
After adjustment for sex and familial his-
tory of hay fever, serum TEQ values were
negatively associated with the odds of having
a positive RAST for house dust mites [odds
ration (OR) = 0.68; p = 0.01], cat dander
(OR = 0.63; p = 0.03), and grass pollen (OR
= 0.70; p = 0.02; Table 4). A history of
upper airway allergy was negatively associ-
ated with serum TEQ values (OR = 0.66; p
= 0.02; Table 4).
Respiratory complaints (Table 4) were
not confounded by meteorological condi-
tions, such as mean daily temperature and
ozone concentration. We found a negative
association between the odds of bronchial
wheezing and serum CALUX TEQ (OR =
0.25; p = 0.03). After adjustment for familial
history of hay fever and/or asthma, the signiﬁ-
cance disappeared (OR = 0.72; p = 0.07).
Before and after similar adjustments, a posi-
tive answer to the question “ever received
medication against asthma” was negatively
associated with serum CALUX TEQ (OR =
0.58; p = 0.005). “Ever asthma” was posi-
tively associated with the serum concentration
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Table 1. Hematologic, immunologic, and exposure measurements in 200 adolescents.
Girls (n = 120) Boys (n = 80)
Measurement (unit) Mean 95% CI Mean 95% CI p-Valuea
Red blood cells (E12/L) 4.55 4.50–4.61 5.07 4.95–5.19 < 0.0001
White blood cells (E9/L) 6.32 6.05–6.59 5.82 5.61–6.18 0.03
Lymphocytes (%) 31.56 30.23–32.89 33.53 31.77–35.30 0.07
Monocytes (%) 6.87 6.56–7.19 7.72 7.04–8.05 0.0004
Trombocytes (E9/L) 258.26 244.69–271.83 223.70 207.66–239.74 0.0014
Eosinophilsb (%) 2.10 1.88–2.34 3.03 2.59–3.53 0.0001
CD3 (%) 66.53 65.21–67.84 60.11 58.40–61.83 < 0.0001
CD4 (%) 38.28 37.10–39.47 33.64 32.26–35.03 < 0.0001
CD8 (%) 21.32 20.35–22.28 20.56 19.38–21.73 0.32
CD19 (%) 13.15 12.35–14.00 14.57 13.63–15.50 0.03
CD45 (%) 96.87 96.08–97.66 96.9 96.57–97.23 0.96
CD4/CD8 1.87 1.76–1.97 1.74 1.62–1.87 0.15
CD16+CD56b (%) 14.42 13.27–15.67 17.70 16.26–19.27 0.002
IgAb (mg/dL) 1.35 1.26–1.45 1.49 1.35–1.65 0.11
IgEb (kIU/L) 17.66 12.85–24.32 41.3 25.82–66.07 0.002
IgGb (mg/dL) 10.09 9.71–10.50 9.51 9.06–10.0 0.07
IgMb (mg/dL) 1.27 1.17–1.37 0.90 0.82–0.99 < 0.0001
CALUX TEQb (pg TEQ/mL) 0.15 0.13–0.17 0.16 0.14–0.19 0.45
CALUX TEQb(pg TEQ/g fat) 28.59 24.93–32.80 34.89 28.66–42.46 0.09
Sum marker PCBsb,c (nmol/L) 0.99 0.90–1.09 1.67 1.51–1.83 < 0.0001
Sum marker PCBsb,c (pmol/g fat) 189.67 172.19–208.45 359.75 326.59–397.19 < 0.0001
Values are arithmetic means with 95% CI except where indicated.
aSigniﬁcance of the difference between girls and boys (Student’s t-test).bGeometric means (logarithmically transformed distribution) with 95% CI. cSum of congeners 138, 153, and 180. of marker PCBs (OR = 2.12; p = 0.05) even
after correction. The odds of suffering from
hay fever increased with higher serum PCB
concentrations (OR = 1.63; p = 0.04).
However, after correcting for sex, signiﬁcance
disappeared, because in our study, hay fever
was more frequently reported by boys (31%)
than by girls (17%).
When we expressed the serum concen-
trations of PCBs or dioxin-like compounds
per gram of fat rather than per volumetric
unit, dose–effect and dose–response relation-
ships were similar.
Discussion
In this study we report on the immune status
of 200 Flemish adolescents in relation to
their exposure to PCBs and dioxins. The
serum concentration of dioxin-like com-
pounds was negatively and independently
correlated with a history of upper airway
allergy and “ever received medication against
asthma,” with eosinophil counts, with serum
concentrations of IgEs, and with the odds of
having a positive RAST for house dust mites,
cat dander, and grass pollen. The serum con-
centration of dioxin-like compounds was
negatively associated with the proportions of
NK cells and monocytes but positively asso-
ciated with serum IgA levels. The changes in
the immune system may reflect a decreased
susceptibility to allergic reactions, as sug-
gested by Weisglas-Kuperus (18).
In the present study we measured the
serum concentrations of dioxin-like com-
pounds by the mechanistically based
CALUX bioassay, which measures all com-
pounds in the serum that act via binding to
the AhR. This direct toxicity measure of
dioxin-like activity may be a more relevant
exposure estimate than chemical analyses of
individual dioxin/furan congeners that are
added after multiplication with their respec-
tive toxic equivalent factors (TEF values).
Furthermore, we determined PCB con-
geners 138, 153, and 180, which account
for only 40–60% of the total PCB burden
(32). Only PCB 118 has a weak dioxin
activity, with a TEF value of 0.0001 (33).
We less frequently found signiﬁcant associa-
tions between immune effects and the com-
bined levels of marker PCBs. The PCB
congeners that we measured in this study
may not be those with the greatest toxicity
to the immune system.
Multiple cellular targets within the
immune-hematopoietic system can be
altered by dioxin-like compounds (34,35).
In experimental systems (animal and in vitro
experiments), PCB/dioxin exposure leads to
suppression of humoral and cell-mediated
immunity and has direct effects on
hematopoietic stem cells and B-cell or T-cell
differentiation (8,11,36,37). However, the
underlying mechanisms for these effects have
not been fully elucidated. Epidemiologic
studies have shown modulation of white
blood cell counts, distribution of lymphocyte
subsets, and the amount of immunoglobulins
in serum by PCB/PCDD exposure (7,8,10).
However, published data on the effects of
dioxin-like compounds on these measure-
ments are often incomplete. Studies often
lack individual quantification of the body
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Table 2. Percentage of adolescents with positive RASTs or positive personal or familial history of allergic
or bronchial disorders.
Positive test or history Girls (n = 120) Boys (n = 80) p-Valuea
RAST
House dust mite 18.3 31.3 0.04
Cat dander 5.8 13.7 0.08
Grass pollen 19.2 37.5 0.005
Birch 4.2 20.0 0.0006
Overallb 27.5 46.3 0.01
History of allergic disease
Upper airways 11.7 20.0 0.11
Lower airways 3.3 10.0 0.07
Eyes 0 1.3 0.40
Skin 7.5 10.0 0.61
Overall 20.0 32.5 0.07
History of infectious disease
Bacterial infections 8.3 1.3 0.05
Viral infections 57.5 58.8 0.88
Overall infections 60.8 60.0 1.00
History of respiratory symptoms
Bronchial wheezing 19.2 13.8 0.34
Hay fever 16.7 31.3 0.02
Ever asthma 6.7 11.3 0.31
Asthma attack last year 3.3 2.5 0.66
Familial history
Hay fever 45.0 27.5 0.01
Asthma 15.8 12.5 0.54
aSigniﬁcance of the difference between girls and boys (Fisher’s exact test). bPositive to any of the four RASTs. 
Table 3. Dose–effect relationships between various immunologic measurements and the biomarkers of exposure to polychlorinated hydrocarbons.
Dioxin-like compounds in serum (pg CALUX TEQ/mL) Combined marker PCBs (nmol/L)a
Partial correlation Estimate Partial correlation Estimate
Biomarker of effect (unit) coefﬁcient r (SE) p-Value coefﬁcient r (SE) p-Value
Red blood cells (E12/L) –0.11 –0.408 (0.24) 0.09 –0.03 –0.007 (0.02) 0.66
White blood cells (E9/L) 0.10 1.177 (0.87) 0.18 0.06 0.044 (0.06) 0.48
Lymphocytes (%) –0.07 –4.368 (4.28) 0.31 –0.11 –0.399 (0.30) 0.18
Monocytes (%) –0.13 –1.699 (0.88) 0.055 –0.10 –0.082 (0.06) 0.19
Thrombocytes (E9/L) 0.015 8.80 (41.29) 0.83 –0.03 –1.04 (2.90) 0.72
Eosinophils (%) –0.18 –0.408 (0.15) 0.009 0.005 0.0008 (0.01) 0.95
CD3 (%)  0.09 5.87 (4.18) 0.16 0.05 0.19 (0.28) 0.49
CD4 (%) 0.05 2.46 (3.60) 0.49 0.10 0.35 (0.25) 0.16
CD8 (%) 0.03 1.31 (3.0) 0.66 –0.05 –0.13 (0.21) 0.54
CD19 (%) 0.02 0.81 (2.45) 0.74 0.04 0.08 (0.17) 0.64
CD45 (%) 0.03 0.93 (2.0) 0.64 –0.05 –0.09 (0.14) 0.53
CD16+CD56 (%) –0.13 –0.20 (0.1) 0.05 –0.08 –0.29 (0.26) 0.27
CD4/CD8 0.01 0.04 (0.33) 0.91 0.11 0.03 (0.02) 0.16
IgA (mg/dL) 0.14 0.20 (0.1) 0.05 0.06 0.005 (0.007) 0.47
IgE (kIU/L) –0.16 –1.08 (0.46) 0.02 –0.04 –0.015 (0.03) 0.65
IgG (mg/dL) 0.04 0.03 (0.05) 0.56 –0.20 –0.009 (0.004) 0.009
IgM (mg/dL) –0.01 –0.02 (0.1) 0.88 0.002 0.0002 (0.007) 0.97
We adjusted the partial correlation coefﬁcients for sex and current smoking.
aSum of congeners 138, 153, and 180.burden or report only between-group differ-
ences instead of dose–effect or dose–response
relationships. In the adolescents in this study,
we found significant associations between
biomarkers of immunologic status and bio-
markers of internal PHAH exposure.
Changes in cell surface markers on T cells
represent an apparently sensitive biomarker
response to the effects of dioxin-like com-
pounds in rodents and primates. Dioxin-like
compounds can affect the primary immune
response by changing the CD4/CD8 ratio or
the ratio of other lymphocyte subpopulations
(11,15,19,38–41). In the present study we
found no associations between T-helper or T-
suppressor cells and the serum PCB/CALUX
TEQ levels. In our adolescents, the numbers
of NK cells (CD16+CD56+ cells), eosinophils,
and monocytes showed negative correlations
with the concentration of dioxin-like com-
pounds in the serum. These findings are in
agreement with a study in Dutch infants in
which exposure was associated with lower
monocyte counts (21) and with a Swedish
study that indicated that consumers of persis-
tent organochlorine compound-contaminated
fish had lower proportions and numbers of
NK cells (42).
Reduced numbers of monocytes and NK
cells (CD16+CD56+ cells) may be an indica-
tion of depressed cellular immunity (34).
However, the present associations were of
borderline significance and should be care-
fully interpreted. The body burden of dioxin-
like substances in our young study group
could have been too low to induce consider-
able alterations in the subpopulation of white
blood cells. Alternatively, the immunosup-
pressive effect of dioxin-like compounds
might be mediated by a decreased functional-
ity of individual cells rather than by a reduc-
tion in absolute cell numbers in the
peripheral blood.
In humans, dioxin-like compounds can
act on B cells, resulting in an impairment of
antibody production (40,43). In our study
we measured the serum concentrations of
immunoglobulins (IgA, IgM, IgG, IgE) as
biomarkers of humoral immunity. We
observed a positive correlation between
serum IgA and serum TEQ/mL but a nega-
tive correlation between serum IgE and
serum TEQ/mL. Both correlations were
weak and only borderline significant.
Furthermore, in experimental animals such
as monkeys, PCBs affect the primary anti-
body response, as evidenced by the depressed
antibody response to sheep red blood cells
(44,45). However, in the present study none
of the serum immunoglobulins correlated
with the combined concentration of marker
PCBs in serum. 
Positive associations between serum IgA
levels and TCDD exposure have been found
in the residents of Missouri as well as in
Vietnam veterans (40,46). The latter have
been exposed to TCDD through use of the
pesticide Agent Orange.
Because serum immunoglobulin levels
do not necessarily reflect the specific
immune responses to common respiratory
allergens, we also performed RASTs. We
noticed a negative association between the
odds of having a positive response to house
dust mites, cat dander, or grass pollen and
the serum concentration of dioxin-like
compounds. To the best of our knowledge,
data on specific IgE levels in relation to
PCB/TCDD exposure levels have not yet
been reported. Reduced antigen-speciﬁc IgG
antibody responses after mumps and rubella
vaccination have been reported in perinatally
exposed Dutch children (18).
Immune deﬁciency generally manifests as
an increased susceptibility to infections.
Increased infection rates (e.g., severe cases of
the common cold) are difﬁcult to ascertain in
epidemiologic surveys (34,35). Wildlife popu-
lations show increased susceptibility to bacter-
ial and viral infections after PCB/TCDD
exposure (12,13). Mononuclear phagocytic
cells of PCB-exposed experimental animals
show reduced phagocytic activity (39). In ani-
mals, therefore, PCB exposure may be associ-
ated with a decreased clearance of pathogenic
bacteria by the spleen and liver, a diminished
resistance to viruses, and an increased sensitiv-
ity to bacterial endotoxins (7). One-year-old
Inuits who were breast-fed with milk contam-
inated with PCBs (621 µg/kg) showed a 20-
fold higher incidence of infectious diseases,
such as measles, meningitis, and otitis media
compared with age-matched controls (20).
Yucheng children born between July 1978
and June 1987 to women accidentally
exposed to PCBs/PCDFs through the con-
sumption of contaminated rice bran oil
showed a higher rate of bronchitis, compared
with controls, in the first 6 months after
birth and higher frequencies of respiratory
tract infections and otitis media attacks in a
6-year follow-up (47). Higher prevalences of
recurrent middle-ear infections and of
chicken pox were positively associated with
current PCB body burden in Dutch
preschool children (18). A higher dioxin
TEQ was also associated with a higher
prevalence of coughing, chest congestion,
and phlegm (18). The same Dutch study
(18) showed a negative association between
prenatal PCB exposure and shortness of
breath with wheezing, whereas the current
PCB burden was associated with a lower
prevalence of allergic reactions. Suppression
of the allergic immune response after
TCDD exposure was recently observed in a
rat model (48). In this study, history of aller-
gic and respiratory complaints were also
negatively associated with the serum concen-
tration of dioxin-like activity.
In conclusion, we found in 17- to 18-
year-old adolescents that biomarkers of inter-
nal exposure to PHAHs, in particular,
dioxin-like compounds, were related to bio-
markers of immune status. The effects of
exposure to dioxin-like compounds in adoles-
cents were associated with a lower prevalence
of allergic diseases.
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Table 4. Dose–response relationship between the odds of a positive RAST or history of allergic or
bronchial disease and the biomarkers of exposure to polychlorinated hydrocarbons.
Dioxin-like compounds in serum Combined marker PCBs
(pg CALUX TEQ/mL) (nmol/L)a
Biomarker of effect OR (95% CI) p-Value OR (95% CI) p-Value
Positive RASTb
House dust mite 0.68 (0.50–0.93) 0.01 0.77 (0.45–1.31) 0.33
Cat dander 0.63 (0.42–0.96) 0.03 0.99 (0.44–2.22) 0.98
Grass pollen 0.70 (0.52–0.95) 0.02 1.17 (0.68–1.98) 0.57
Birch 0.77 (0.51–1.14) 0.19 0.91 (0.36–1.32) 0.53
Overall 0.77 (0.58–1.01) 0.06 1.03 (0.64–1.66) 0.92
History of allergic diseaseb
Upper airways 0.66 (0.47–0.93) 0.02 1.18 (0.62–2.25) 0.61
Lower airways 0.87 (0.52–1.47) 0.61 0.94 (0.34–2.55) 0.90
Skin 0.97 (0.62–1.51) 0.88 1.49 (0.66–3.33) 0.34
Overall 0.76 (0.57–1.03) 0.08 1.23 (0.71–2.11) 0.46
History of infectious disease
Bacterial infections 1.86 (0.54–6.42) 0.32 0.97 (0.88–1.07) 0.54
Viral infections 1.38 (0.69–2.76) 0.26 0.97 (0.93–1.00) 0.09
Overall infections 1.30 (0.65–2.62) 0.46 0.96 (0.93–1.01) 0.15
History of respiratory symptomsc
Bronchial wheezing 0.72 (0.51–1.03) 0.07 1.18 (0.69–2.04) 0.55
Hay fever 0.97 (0.71–1.33) 0.86 1.63 (1.02–2.61) 0.04
Ever asthma 0.75 (0.49–1.15) 0.19 2.12 (1.01–4.46) 0.05
Ever medication against asthma 0.58 (0.39–0.85) 0.005 1.02 (0.56–1.87) 0.95
Breathless while wheezing 0.90 (0.46–1.76) 0.75 1.11 (0.46–2.67) 0.81
Wheezing during exertion 0.69 (0.35–1.37) 0.27 1.16 (0.52–2.62) 0.70
aSum of congeners 138, 153, and 180. bAdjusted for sex and family history of hay fever. cAdjusted for family history of hay
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